RUNX3 plays an important role in As2O3-induced apoptosis and allows cells to overcome MSC-mediated drug resistance

Abstract

The interaction between bone marrow stromal cells and leukemia cells is critical for the persistence and progression of leukemia, and this interaction may account for residual disease. However, the link between leukemia cells and their environment is still poorly understood. In our study, runt-related transcription factor 3 (RUNX3) was identified as a novel target gene affected by As2O3 and involved in mesenchymal stem cell (MSC)-mediated protection of leukemia cells from As2O3-induced apoptosis. We observed induction of RUNX3 expression and the translocation of RUNX3 into the nucleus after As2O3 treatment in leukemia cells. In K562 chronic myeloid leukemia cells, downregulation of endogenous RUNX3 compromised As2O3-induced growth inhibition, cell cycle arrest, and apoptosis. In the presence of MSC, As2O3-induced expression of RUNX3 was reduced significantly and this reduction was modulated by CXCL12/CXCR4 signaling. Furthermore, overexpression of RUNX3 restored, at least in part, the sensitivity of leukemic cells to As2O3. We conclude that RUNX3 plays an important role in As2O3-induced cellular responses and allows cells to overcome MSC-mediated drug resistance. Therefore, RUNX3 is a promising target for therapeutic approaches to overcome MSC-mediated drug resistance.